Article Page

Abstract

The existence of any elementary particle in universe requires the existence of some region of universe occupied by it. By taking the volume of this occupied region, the author will reformulate the relativistic quantum field theory using new 3-dimensional region-like idealization of elementary particles and hereinafter will call the total volume of all regions occupied by the elementary constituent particles of the quantum system the occupied volume. Also the author will call the set of all regions of universe filled by elementary constituent particles of the quantum system the occupied path. Always any quantum system is existed at a head of its occupied path. This path is growing by mutual filling and leaving regions of universe by its elementary constituent particles. The conservation of this elementary constituent particle requires the conservation of its occupied volume during this process. This requirement could be summarized by the following conditions: 1) the total volume of all regions of universe filled by the elementary constituent particles of the quantum system minus the total volume of all regions of universe left by these elementary constituent particles must be equal to the occupied volume of the quantum system; 2) the total increase in the occupied volume of the quantum system due to the absorption of another elementary particles from outside its occupied regions minus the total decreasing in its occupied volume due to the emission of another elementary particles outside its occupied regions must be equal to the occupied volume of it. The wave-particle duality of the elementary constituent particles implied accumulation of them as the finite set of interfered waves. This accumulation of elementary constituent particles causes the absolute probabilistic nature of event of finding the elementary consistent particle in specified interfered wave, and hence the mathematical representation of this interfered wave should take into account the value of probability amplitude of finding an elementary particle inside the region occupied specified interfered wave. In quantum theory this probability amplitude corresponds to complex amplitude of the wave function of interfered wave. Also in Hilbert’s representation of the quantum theory these wave functions are representing the components of the quantum state vector. In this paper the author will develop the transformation theory of the region-like quantum state of the quantum system. In this study, we managed to reformulate of the Relativistic Quantum Field Theory using Region-Like Idealization of the Elementary Particle Identification of an one-bead by one-compound computer-aided discovery novel peptide mimetic pharmacophore against human ovarian cancer highly expressed on conserved mRNAs-cDGX4GX6X7c associated combinatorial libraries.

Keywords

Reformulation; Relativistic Quantum Field Theory; Region-Like Idealization; Elementary Particle Identification; one-bead by one-compound; computer-aided discovery; novel peptide mimetic; pharmacophore; human ovarian cancer; highly expressed; fconserved; mRNAs-cDGX4GX6X7c; combinatorial libraries; Creation, Annihilation, Animation, Occupied Volume, Occupied Path,

Article Type

Research Article – Abstract

Publication history

Received: Sep 20, 2017
Accepted: Sep 25, 2017
Published: Oct 01, 2017

Citation

Grigoriadis Ioannis, Grigoriadis George, Grigoriadis Nikolaos, George Galazios (2017) Reformulation of Relativistic Quantum Field Theory Using Region-Like Idealization of the Elementary Particle Identification of an one-bead by one-compound computer-aided discovery novel peptide mimetic pharmacophore against human ovarian cancer highly expressed on conserved mRNAs-cDGX4GX6X7c associated combinatorial libraries.

Authors Info

Grigoriadis Nikolaos
Department of IT Computer Aided Personalized Myoncotherapy, Cartigenea-Cardiogenea, Neurogenea-Cellgenea, Cordigenea-HyperoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

Grigoriadis Ioannis
Department of Computer Drug Discovery Science, BiogenetoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

Grigoriadis George
Department of Stem Cell Bank and ViroGeneaTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

George Galazios
Professor of Obstetrics and Gynecology,
Democritus University of Thrace,
Komotini, Greece;

E-mail: biogeneadrug@gmail.com